Replies to post #9059 on Inergetics Inc (fka NRTI)

[crookedneck]

CBD is the REAL FUTURE for NRTI and given their unique ground breaking approach, they will garner a significant competitive advantage in MJ marketplace that can not be replicated by competition! When the street wakes up and takes notice of this, you will see this stock soar beyond $1.00 real fast!

They will have all the Sceintific & Medical MJ experts in their corner supporting and endorsing their CBD products!

Just read these comments from their impressive Advisory Board after their first meeting and click the news links at the bottom to see where this company is headed next year!!!!!!!!!!!!!!

"We are making clear progress in the development of superior CBD-based products that will offer a natural and workable remedy to patients seeking relief from a range of symptoms," said NRTI Chief Science Officer, Carl Germano, RD, CNS, CDN. "Certain cannabinoids are non-psychoactive, and proven to provide safe and effective relief to those suffering from pain, nausea, neurological disorders and other ailments. I could not have been more pleased with the substance of our discussion, and the plan we have devised for bringing our first CBD product to market."

Advisory Board member Dr. Joseph McSherry, M.D., a Neurologist and widely recognized academic expert on medical marijuana and its many health benefits, said, "An effort such as this is unprecedented. We have come so far since I first started advocating for the medicinal applications of Cannabis, and I am excited about working with this impressive group of colleagues to bring the therapeutic properties of CBD-based supplements to the consumers who could most benefit from them."

"Cannabinoids undoubtedly provide relief from pain and its underlying symptoms, and do so with far fewer side effects than other treatments currently available," said Dr. Mark Wallace, M.D., a member of the Advisory Board and the Chair of the Division of Pain Medicine at University of California San Diego. "CBD is a clear and essential alternative remedy for patients, and I think we are all eager to make this resource available to the public, and at a higher-quality."

Advisory Board member Dr. Michelle Sexton, a certified naturopathic doctor, said, "I look forward to working with this impressive group to take the first critical look at the proper dosage, potency, purity and methods of administration of cannabinoids. Right now there is no clear industry standard, and this team has an opportunity to change that."

"Twenty-five percent of drugs in the market today come from natural sources. Cannabis is just another one of those natural sources that can be used to help patients," said Justin Fischedick, PhD, a member of the Advisory Board and an expert in plant chemistry.

Dr. Yu Shao, Advisory Board member and also a consultant for Merck, added, "Inergetics and Terra Tech can help define the future of medicinal Cannabis, and I am pleased to be a part of this effort."

The strategic partnership between Inergetics and Terra Tech Corp was announced on February 4 and the companies' first CBD-based supplements are expected to be distributed via medicinal marijuana dispensaries. Inergetics announced the formation of the Scientific/Medical Advisory Board on March 5.

IMPORTANT LINKS:

Inergetics Enters Second Phase of a Three Phase Process to Launch its CBD-Based Supplements

Inergetics Completes Phase I Development of its Therapeutic CBD Line of Products

Inergetics Holds Inaugural Meeting of its Scientific/Medical Advisory Board

Inergetics Scientific/Medical Advisory Board Member Dr. Michelle Sexton Co-authors Important Research in the Cannabis Monograph